Clinical Trial Detail

NCT ID NCT02559778
Title Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Giselle Sholler
Indications

neuroblastoma

ganglioneuroblastoma

Therapies

Bortezomib

Crizotinib

Lapatinib

Vorinostat

Eflornithine

Sorafenib

Dasatinib

Age Groups: adult child

No variant requirements are available.